Our findings demonstrate the critical role of miR-155-5p/SOX1/RAF/MEK/ERK axis in CCA progression, which may provide a novel diagnostic and therapeutic target for CCA. The gene discussed is MAP2K7; the disease is cholangiocarcinoma.